Led a six-month launch program spanning development, FDA strategy, global production, distribution, and commercial readiness.
Impact: FDA EUA achieved in three months; global manufacturer secured and a lead-generation funnel established.
Built the U.S. diagnostics operation, including resources, contracting, regulatory planning, commercial strategy, and launch execution.
Impact: Distribution agreements initiated within six months.
Developed the business plan and diagnostics launch strategy to transition research-use products toward clinical applications.
Focus: Market assessment, positioning, pricing, partnerships, and commercial execution.
Helped reposition a stagnant digital pathology business and align sales, marketing, and business development around new growth priorities.
Focus: Targeting, messaging, value proposition, and go-to-market strategy.
Prepared a liquid-biopsy MRD LDT for launch, supporting product requirements, validation planning, clinical positioning, and KOL engagement.
Focus: Product requirements, study planning, value proposition, and launch readiness.
Led marketing and coached the sales organization during a transition from diagnostics products to infectious-disease solutions.
Focus: Leadership, commercial strategy, marketing, and organizational development.
Bill Standwill discusses CRISPR innovation and commercialization.